Overview

Is my product a combination product? Which FDA Center will review my product? How will it be regulated? Sometimes the answers are not obvious. This webinar will begin with addressing these questions. Speakers will then delve into such topics as practices for preparing a Request for Designation (RFD) or Pre-RFD, pre- and post-market requirements for combination products, and other practical and legal considerations. The webinar will also include industry case studies on company hurdles and lessons learned when submitting a product.

Get Access

$99
  • +$100 for nonmembers

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

Speakers

John (Barr) Weiner, Associate Director for Policy in the Food and Drug Administration’s Office of Combination Products
Scott Danzis, Partner, Covington & Burling LLP
Kirsten Paulson, Senior Director, Global Reg- CMC Medical Devices, Pfizer, Inc.

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.

 

On-demand content can be played back on most devices.

 

CLE credit is not currently available for pre-recorded sessions.

Related Content